A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Clinical trial NCT00730158 · COMPLETED
Trial details
- NCT number
- NCT00730158
- Sponsor
- Edward Chu, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2016-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.